Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 9/2017

01-09-2017 | Reproductive Physiology and Disease

Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield

Authors: Joseph M. Letourneau, Hakan Cakmak, Molly Quinn, Nikita Sinha, Marcelle I. Cedars, Mitchell P. Rosen

Published in: Journal of Assisted Reproduction and Genetics | Issue 9/2017

Login to get access

Abstract

Purpose

Unlike infertility, patients presenting for fertility preservation (FP) are often using combined hormonal contraceptives (CHC). We studied whether long-term (≥6 months) CHC use is associated with reversible suppression of antral follicle count (AFC).

Methods

This is a longitudinal study of FP cycles from 2012 to 2016. We studied three groups: those without CHC exposure (NO CHC), those with CHC usage with a CHC break (BREAK), and without a break (NO BREAK) prior to ovarian stimulation. We assessed ovarian reserve by AFC at initial consultation and discussed the possibility of CHC suppression of AFC. Patients chose between ovarian stimulation with no CHC break versus ovarian stimulation after a CHC break. AFC was measured serially in the BREAK group. We assessed whether AFC suppression was reversed in the BREAK group. Total oocyte yield was compared among the NO CHC, BREAK, and NO BREAK groups. T tests, ANOVA, and linear/logistic regressions were used.

Results

Seven hundred forty-three women underwent FP. Twenty-one percent (n = 154) were taking long-term CHC (≥6 months). AFC suppression was more likely with CHC use (OR 1.6, 95% CI 1.1–2.4, P = 0.011). The BREAK group (n = 79) stopped CHC for an average of 4 months. AFC improvement started at 1 month and plateaued at approximately 6- to 7-month break. The BREAK group had approximately twice as many oocytes per initial AFC as NO BREAK (2.8 ± 3.8 vs. 1.4 ± 0.9, P < 0.001).

Conclusions

When women present for FP on CHC, AFC may be suppressed. A CHC break of several months is associated with an increase in AFC and a potential improvement in overall egg yield.
Literature
1.
go back to reference Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril Elsevier. 2015;103:1551–6.e1–4.CrossRef Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril Elsevier. 2015;103:1551–6.e1–4.CrossRef
2.
go back to reference Rebar RW. Social and ethical implications of fertility preservation. Fertil Steril Am Soc Reprod Med 2016:1–3. Rebar RW. Social and ethical implications of fertility preservation. Fertil Steril Am Soc Reprod Med 2016:1–3.
3.
go back to reference Petropanagos A. Reproductive “choice” and egg freezing. In: Woodruff TK, Zoloth L, Campo-Engelstein L, Rodriguez S, editors. Oncofertility. Boston: Springer US; 2010. p. 223–35.CrossRef Petropanagos A. Reproductive “choice” and egg freezing. In: Woodruff TK, Zoloth L, Campo-Engelstein L, Rodriguez S, editors. Oncofertility. Boston: Springer US; 2010. p. 223–35.CrossRef
4.
go back to reference National Center for Health Statistics. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. 2015:1–15. National Center for Health Statistics. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. 2015:1–15.
5.
go back to reference Kovacs P, Barg PE, Witt BR. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet Springer. 2001;18:391–4.CrossRef Kovacs P, Barg PE, Witt BR. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet Springer. 2001;18:391–4.CrossRef
6.
go back to reference Cohen BL, Katz M. Pituitary and ovarian function in women receiving hormonal contraception. Contraception. 1979;20:475–87.CrossRefPubMed Cohen BL, Katz M. Pituitary and ovarian function in women receiving hormonal contraception. Contraception. 1979;20:475–87.CrossRefPubMed
7.
go back to reference Tran ND, Aghajanova L, Kao C-N, Cedars MI, Rosen MP. Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation. Fertil Steril. 2016;105:690–6.CrossRefPubMed Tran ND, Aghajanova L, Kao C-N, Cedars MI, Rosen MP. Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation. Fertil Steril. 2016;105:690–6.CrossRefPubMed
8.
go back to reference Yu Ng EH, Chi Wai Chan C, Tang OS, Shu Biu Yeung W, Chung Ho P. Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation. Hum Reprod Oxford Univ Press. 2004;19:2811–5.CrossRef Yu Ng EH, Chi Wai Chan C, Tang OS, Shu Biu Yeung W, Chung Ho P. Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation. Hum Reprod Oxford Univ Press. 2004;19:2811–5.CrossRef
9.
go back to reference Wan LS, Ganguly M, Weiss G. Pituitary response to LHRH stimulation in women on oral contraceptives: a follow up dose response study. Contraception. 1981;24:229–34.CrossRefPubMed Wan LS, Ganguly M, Weiss G. Pituitary response to LHRH stimulation in women on oral contraceptives: a follow up dose response study. Contraception. 1981;24:229–34.CrossRefPubMed
10.
go back to reference Cohen BL, Katz M. Further studies on pituitary and ovarian function in women receiving hormonal contraception. Contraception. 1981;24:159–72.CrossRefPubMed Cohen BL, Katz M. Further studies on pituitary and ovarian function in women receiving hormonal contraception. Contraception. 1981;24:159–72.CrossRefPubMed
11.
go back to reference Scott JZ, Kletzky OA, Brenner PF, Mishell DR. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Fertil Steril. 1978;30:141–5.CrossRefPubMed Scott JZ, Kletzky OA, Brenner PF, Mishell DR. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Fertil Steril. 1978;30:141–5.CrossRefPubMed
12.
go back to reference Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod BioMed Online. 2015;31:486–96.CrossRefPubMed Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod BioMed Online. 2015;31:486–96.CrossRefPubMed
13.
go back to reference Kotanidis L, Nikolettos K, Petousis S, Asimakopoulos B, Chatzimitrou E, Kolios G, et al. The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF. J Endocrinol Invest Springer Int Publ. 2016;39:1459–64.CrossRef Kotanidis L, Nikolettos K, Petousis S, Asimakopoulos B, Chatzimitrou E, Kolios G, et al. The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF. J Endocrinol Invest Springer Int Publ. 2016;39:1459–64.CrossRef
14.
go back to reference Moon KY, Kim H, Lee JY, Lee JR, Jee BC, Suh CS, et al. Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation. Clin Exp Reprod Med. 2016;43:112–8.CrossRefPubMedPubMedCentral Moon KY, Kim H, Lee JY, Lee JR, Jee BC, Suh CS, et al. Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation. Clin Exp Reprod Med. 2016;43:112–8.CrossRefPubMedPubMedCentral
15.
go back to reference Rosen MP, Johnstone E, McCulloch CE, Schuh-Huerta SM, Sternfeld B, Reijo-Pera RA, et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril. 2012;97:238–43.CrossRefPubMed Rosen MP, Johnstone E, McCulloch CE, Schuh-Huerta SM, Sternfeld B, Reijo-Pera RA, et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril. 2012;97:238–43.CrossRefPubMed
16.
go back to reference Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2010;8:56–60.CrossRefPubMedPubMedCentral Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2010;8:56–60.CrossRefPubMedPubMedCentral
17.
go back to reference Birch Petersen K, Hvidman HW, Forman JL, Pinborg A, Larsen EC, Macklon KT, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod Oxford Univ Press. 2015;30:2364–75.CrossRef Birch Petersen K, Hvidman HW, Forman JL, Pinborg A, Larsen EC, Macklon KT, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod Oxford Univ Press. 2015;30:2364–75.CrossRef
18.
go back to reference Bentzen JG, Forman JL, Pinborg A, Lidegaard Ø, Larsen EC, Friis-Hansen L, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod BioMed Online. 2012;25:612–9.CrossRefPubMed Bentzen JG, Forman JL, Pinborg A, Lidegaard Ø, Larsen EC, Friis-Hansen L, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod BioMed Online. 2012;25:612–9.CrossRefPubMed
19.
go back to reference Deb S, Campbell BK, Pincott-Allen C, Clewes JS, Cumberpatch G, Raine-Fenning NJ. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound Obstet Gynecol John Wiley & Sons, Ltd. 2012;39:574–80.CrossRef Deb S, Campbell BK, Pincott-Allen C, Clewes JS, Cumberpatch G, Raine-Fenning NJ. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound Obstet Gynecol John Wiley & Sons, Ltd. 2012;39:574–80.CrossRef
20.
go back to reference van den Berg MH, van Dulmen-den Broeder E, Overbeek A, Twisk JWR, Schats R, van Leeuwen FE, et al. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod. 2010;25:1520–7.CrossRefPubMed van den Berg MH, van Dulmen-den Broeder E, Overbeek A, Twisk JWR, Schats R, van Leeuwen FE, et al. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod. 2010;25:1520–7.CrossRefPubMed
21.
go back to reference Cobo A, Garcia-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocytes vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755–64. Cobo A, Garcia-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocytes vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755–64.
22.
go back to reference Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP. Response to controlled ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod. 2017;32(3):568–74. Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP. Response to controlled ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod. 2017;32(3):568–74.
23.
go back to reference Lawrenz B, Fehm T, Wolff von M, Soekler M, Huebner S, Henes J, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma—evaluation by using antimüllerian hormone and retrieved oocytes. Fertil Steril. 2012;98:141–4.CrossRefPubMed Lawrenz B, Fehm T, Wolff von M, Soekler M, Huebner S, Henes J, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma—evaluation by using antimüllerian hormone and retrieved oocytes. Fertil Steril. 2012;98:141–4.CrossRefPubMed
24.
go back to reference Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97:125–33.CrossRefPubMed Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97:125–33.CrossRefPubMed
25.
go back to reference Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ. Impact of breast cancer on anti-mullerian hormone levels in young women. Breast Cancer Res Treat. 2012;137:571–7.CrossRefPubMedPubMedCentral Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ. Impact of breast cancer on anti-mullerian hormone levels in young women. Breast Cancer Res Treat. 2012;137:571–7.CrossRefPubMedPubMedCentral
26.
go back to reference Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: early clinical experience. Fertil Steril Elsevier. 2010;94:149–55.CrossRef Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: early clinical experience. Fertil Steril Elsevier. 2010;94:149–55.CrossRef
27.
go back to reference Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol. 1995;9:299–305.CrossRefPubMed Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol. 1995;9:299–305.CrossRefPubMed
28.
go back to reference Roumen FJME. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception. 2007;75:420–9.CrossRefPubMed Roumen FJME. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception. 2007;75:420–9.CrossRefPubMed
29.
go back to reference Duijkers IJM, Klipping C, Verhoeven CHJ, Dieben TOM. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. Hum Reprod Oxford Univ Press. 2004;19:2668–73.CrossRef Duijkers IJM, Klipping C, Verhoeven CHJ, Dieben TOM. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. Hum Reprod Oxford Univ Press. 2004;19:2668–73.CrossRef
Metadata
Title
Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield
Authors
Joseph M. Letourneau
Hakan Cakmak
Molly Quinn
Nikita Sinha
Marcelle I. Cedars
Mitchell P. Rosen
Publication date
01-09-2017
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 9/2017
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-017-0981-8

Other articles of this Issue 9/2017

Journal of Assisted Reproduction and Genetics 9/2017 Go to the issue